We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEI
12551
CALL
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$61K ﹤0.01%
6,400
+1,573
+33% +$21K
ABTS icon
12552
CALL
Abits Group
ABTS
$3.73M
$60K ﹤0.01%
2,480
-2,213
-47% -$65.3K
ACB
12553
Aurora Cannabis
ACB
$179M
$60K ﹤0.01%
1,505
-124,675
-99% -$5.28M
CUE icon
12554
Cue Biopharma
CUE
$110M
$60K ﹤0.01%
412
-300
-42% -$63.6K
KRRO icon
12555
CALL
Korro Bio
KRRO
$199M
$60K ﹤0.01%
568
+54
+11% +$10.3K
LAB icon
12556
CALL
Standard BioTools
LAB
$310M
$60K ﹤0.01%
16,600
-17,700
-52% -$61.1K
LYG icon
12557
CALL
Lloyds Banking Group
LYG
$89B
$60K ﹤0.01%
+24,700
New +$65.7K
PHK
12558
PIMCO High Income Fund
PHK
$878M
$60K ﹤0.01%
10,367
-924
-8% -$5.45K
QMCO icon
12559
Quantum Corp
QMCO
$464M
$60K ﹤0.01%
1,320
-4,388
-77% -$321K
RTB
12560
RTB Digital
RTB
$228M
$60K ﹤0.01%
+41
New +$51.2K
STKL
12561
PUT
DELISTED
SunOpta
STKL
$60K ﹤0.01%
11,900
+700
+6% +$3.69K
TXMD icon
12562
CALL
TherapeuticsMD
TXMD
$24M
$60K ﹤0.01%
3,166
-3,576
-53% -$56.2K
UONEK icon
12563
Urban One Class D
UONEK
$24.5M
$60K ﹤0.01%
+1,169
New +$50.4K
QCLS
12564
Q/C Technologies Inc
QCLS
$22.1M
$60K ﹤0.01%
4
-2
-33% -$25.4K
GENE
12565
PUT
DELISTED
Genetic Technologies Ltd.
GENE
$60K ﹤0.01%
6,120
-2,180
-26% -$21.2K
SDACW
12566
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$60K ﹤0.01%
200,141
-57,698
-22% -$22.5K
PEARW
12567
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$60K ﹤0.01%
75,978
-3,233
-4% -$2.26K
TMDI
12568
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$60K ﹤0.01%
114,006
-83,671
-42% -$48.5K
FINMW
12569
DELISTED
Marlin Technology Corporation Warrant
FINMW
$60K ﹤0.01%
200,211
-155,764
-44% -$75.1K
HLAHW
12570
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
$60K ﹤0.01%
224,021
+479
+0.2% +$215
AFI
12571
DELISTED
Armstrong Flooring, Inc.
AFI
$60K ﹤0.01%
+42,173
New +$73.5K
BDTX icon
12572
PUT
Black Diamond Therapeutics
BDTX
$114M
$59K ﹤0.01%
21,400
+2,700
+14% +$9.86K
NUVB.WS
12573
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$59K ﹤0.01%
73,606
+187
+0.3% +$188
PLG
12574
CALL
Platinum Group Metals
PLG
$203M
$59K ﹤0.01%
27,900
+14,000
+101% +$27K
GOTU icon
12575
Gaotu Techedu
GOTU
$444M
$58K ﹤0.01%
33,781
-255,529
-88% -$486K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.